Copyright Reports & Markets. All rights reserved.

Global Liver Cancer Treatment Drug Market 2025 by Company, Regions, Type and Application, Forecast to 2031

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Classification of Liver Cancer Treatment Drug by Type
    • 1.3.1 Overview: Global Liver Cancer Treatment Drug Market Size by Type: 2020 Versus 2024 Versus 2031
    • 1.3.2 Global Liver Cancer Treatment Drug Consumption Value Market Share by Type in 2024
    • 1.3.3 Targeted Therapy
    • 1.3.4 Radiation Therapy
    • 1.3.5 Immunotherapy
    • 1.3.6 Chemotherapy
    • 1.3.7 Other
  • 1.4 Global Liver Cancer Treatment Drug Market by Application
    • 1.4.1 Overview: Global Liver Cancer Treatment Drug Market Size by Application: 2020 Versus 2024 Versus 2031
    • 1.4.2 Hepatocellular Carcinoma
    • 1.4.3 Cholangio Carcinoma
    • 1.4.4 Hepatoblastoma
    • 1.4.5 Other
  • 1.5 Global Liver Cancer Treatment Drug Market Size & Forecast
  • 1.6 Global Liver Cancer Treatment Drug Market Size and Forecast by Region
    • 1.6.1 Global Liver Cancer Treatment Drug Market Size by Region: 2020 VS 2024 VS 2031
    • 1.6.2 Global Liver Cancer Treatment Drug Market Size by Region, (2020-2031)
    • 1.6.3 North America Liver Cancer Treatment Drug Market Size and Prospect (2020-2031)
    • 1.6.4 Europe Liver Cancer Treatment Drug Market Size and Prospect (2020-2031)
    • 1.6.5 Asia-Pacific Liver Cancer Treatment Drug Market Size and Prospect (2020-2031)
    • 1.6.6 South America Liver Cancer Treatment Drug Market Size and Prospect (2020-2031)
    • 1.6.7 Middle East & Africa Liver Cancer Treatment Drug Market Size and Prospect (2020-2031)

2 Company Profiles

  • 2.1 4SC AG
    • 2.1.1 4SC AG Details
    • 2.1.2 4SC AG Major Business
    • 2.1.3 4SC AG Liver Cancer Treatment Drug Product and Solutions
    • 2.1.4 4SC AG Liver Cancer Treatment Drug Revenue, Gross Margin and Market Share (2020-2025)
    • 2.1.5 4SC AG Recent Developments and Future Plans
  • 2.2 Alnylam Pharmaceuticals, Inc.
    • 2.2.1 Alnylam Pharmaceuticals, Inc. Details
    • 2.2.2 Alnylam Pharmaceuticals, Inc. Major Business
    • 2.2.3 Alnylam Pharmaceuticals, Inc. Liver Cancer Treatment Drug Product and Solutions
    • 2.2.4 Alnylam Pharmaceuticals, Inc. Liver Cancer Treatment Drug Revenue, Gross Margin and Market Share (2020-2025)
    • 2.2.5 Alnylam Pharmaceuticals, Inc. Recent Developments and Future Plans
  • 2.3 AVEO Pharmaceuticals, Inc
    • 2.3.1 AVEO Pharmaceuticals, Inc Details
    • 2.3.2 AVEO Pharmaceuticals, Inc Major Business
    • 2.3.3 AVEO Pharmaceuticals, Inc Liver Cancer Treatment Drug Product and Solutions
    • 2.3.4 AVEO Pharmaceuticals, Inc Liver Cancer Treatment Drug Revenue, Gross Margin and Market Share (2020-2025)
    • 2.3.5 AVEO Pharmaceuticals, Inc Recent Developments and Future Plans
  • 2.4 Bayer AG
    • 2.4.1 Bayer AG Details
    • 2.4.2 Bayer AG Major Business
    • 2.4.3 Bayer AG Liver Cancer Treatment Drug Product and Solutions
    • 2.4.4 Bayer AG Liver Cancer Treatment Drug Revenue, Gross Margin and Market Share (2020-2025)
    • 2.4.5 Bayer AG Recent Developments and Future Plans
  • 2.5 Becton, Dickinson and Co.
    • 2.5.1 Becton, Dickinson and Co. Details
    • 2.5.2 Becton, Dickinson and Co. Major Business
    • 2.5.3 Becton, Dickinson and Co. Liver Cancer Treatment Drug Product and Solutions
    • 2.5.4 Becton, Dickinson and Co. Liver Cancer Treatment Drug Revenue, Gross Margin and Market Share (2020-2025)
    • 2.5.5 Becton, Dickinson and Co. Recent Developments and Future Plans
  • 2.6 Bristol-Myers Squibb Co.
    • 2.6.1 Bristol-Myers Squibb Co. Details
    • 2.6.2 Bristol-Myers Squibb Co. Major Business
    • 2.6.3 Bristol-Myers Squibb Co. Liver Cancer Treatment Drug Product and Solutions
    • 2.6.4 Bristol-Myers Squibb Co. Liver Cancer Treatment Drug Revenue, Gross Margin and Market Share (2020-2025)
    • 2.6.5 Bristol-Myers Squibb Co. Recent Developments and Future Plans
  • 2.7 Celsion Corp.
    • 2.7.1 Celsion Corp. Details
    • 2.7.2 Celsion Corp. Major Business
    • 2.7.3 Celsion Corp. Liver Cancer Treatment Drug Product and Solutions
    • 2.7.4 Celsion Corp. Liver Cancer Treatment Drug Revenue, Gross Margin and Market Share (2020-2025)
    • 2.7.5 Celsion Corp. Recent Developments and Future Plans
  • 2.8 Dicerna Pharmaceuticals, Inc.
    • 2.8.1 Dicerna Pharmaceuticals, Inc. Details
    • 2.8.2 Dicerna Pharmaceuticals, Inc. Major Business
    • 2.8.3 Dicerna Pharmaceuticals, Inc. Liver Cancer Treatment Drug Product and Solutions
    • 2.8.4 Dicerna Pharmaceuticals, Inc. Liver Cancer Treatment Drug Revenue, Gross Margin and Market Share (2020-2025)
    • 2.8.5 Dicerna Pharmaceuticals, Inc. Recent Developments and Future Plans
  • 2.9 Eli Lilly and Co.
    • 2.9.1 Eli Lilly and Co. Details
    • 2.9.2 Eli Lilly and Co. Major Business
    • 2.9.3 Eli Lilly and Co. Liver Cancer Treatment Drug Product and Solutions
    • 2.9.4 Eli Lilly and Co. Liver Cancer Treatment Drug Revenue, Gross Margin and Market Share (2020-2025)
    • 2.9.5 Eli Lilly and Co. Recent Developments and Future Plans
  • 2.10 Exelixis, Inc.
    • 2.10.1 Exelixis, Inc. Details
    • 2.10.2 Exelixis, Inc. Major Business
    • 2.10.3 Exelixis, Inc. Liver Cancer Treatment Drug Product and Solutions
    • 2.10.4 Exelixis, Inc. Liver Cancer Treatment Drug Revenue, Gross Margin and Market Share (2020-2025)
    • 2.10.5 Exelixis, Inc. Recent Developments and Future Plans
  • 2.11 F. Hoffmann-La Roche, Ltd.
    • 2.11.1 F. Hoffmann-La Roche, Ltd. Details
    • 2.11.2 F. Hoffmann-La Roche, Ltd. Major Business
    • 2.11.3 F. Hoffmann-La Roche, Ltd. Liver Cancer Treatment Drug Product and Solutions
    • 2.11.4 F. Hoffmann-La Roche, Ltd. Liver Cancer Treatment Drug Revenue, Gross Margin and Market Share (2020-2025)
    • 2.11.5 F. Hoffmann-La Roche, Ltd. Recent Developments and Future Plans
  • 2.12 FibroGen, Inc.
    • 2.12.1 FibroGen, Inc. Details
    • 2.12.2 FibroGen, Inc. Major Business
    • 2.12.3 FibroGen, Inc. Liver Cancer Treatment Drug Product and Solutions
    • 2.12.4 FibroGen, Inc. Liver Cancer Treatment Drug Revenue, Gross Margin and Market Share (2020-2025)
    • 2.12.5 FibroGen, Inc. Recent Developments and Future Plans
  • 2.13 General Electric Co.(GE Healthcare)
    • 2.13.1 General Electric Co.(GE Healthcare) Details
    • 2.13.2 General Electric Co.(GE Healthcare) Major Business
    • 2.13.3 General Electric Co.(GE Healthcare) Liver Cancer Treatment Drug Product and Solutions
    • 2.13.4 General Electric Co.(GE Healthcare) Liver Cancer Treatment Drug Revenue, Gross Margin and Market Share (2020-2025)
    • 2.13.5 General Electric Co.(GE Healthcare) Recent Developments and Future Plans
  • 2.14 Merck & Co., Inc.(ArQule, Inc.)
    • 2.14.1 Merck & Co., Inc.(ArQule, Inc.) Details
    • 2.14.2 Merck & Co., Inc.(ArQule, Inc.) Major Business
    • 2.14.3 Merck & Co., Inc.(ArQule, Inc.) Liver Cancer Treatment Drug Product and Solutions
    • 2.14.4 Merck & Co., Inc.(ArQule, Inc.) Liver Cancer Treatment Drug Revenue, Gross Margin and Market Share (2020-2025)
    • 2.14.5 Merck & Co., Inc.(ArQule, Inc.) Recent Developments and Future Plans
  • 2.15 Novartis International AG
    • 2.15.1 Novartis International AG Details
    • 2.15.2 Novartis International AG Major Business
    • 2.15.3 Novartis International AG Liver Cancer Treatment Drug Product and Solutions
    • 2.15.4 Novartis International AG Liver Cancer Treatment Drug Revenue, Gross Margin and Market Share (2020-2025)
    • 2.15.5 Novartis International AG Recent Developments and Future Plans
  • 2.16 Nymox Corp.
    • 2.16.1 Nymox Corp. Details
    • 2.16.2 Nymox Corp. Major Business
    • 2.16.3 Nymox Corp. Liver Cancer Treatment Drug Product and Solutions
    • 2.16.4 Nymox Corp. Liver Cancer Treatment Drug Revenue, Gross Margin and Market Share (2020-2025)
    • 2.16.5 Nymox Corp. Recent Developments and Future Plans
  • 2.17 Pfizer, Inc.
    • 2.17.1 Pfizer, Inc. Details
    • 2.17.2 Pfizer, Inc. Major Business
    • 2.17.3 Pfizer, Inc. Liver Cancer Treatment Drug Product and Solutions
    • 2.17.4 Pfizer, Inc. Liver Cancer Treatment Drug Revenue, Gross Margin and Market Share (2020-2025)
    • 2.17.5 Pfizer, Inc. Recent Developments and Future Plans
  • 2.18 SMC Laboratories, Inc.
    • 2.18.1 SMC Laboratories, Inc. Details
    • 2.18.2 SMC Laboratories, Inc. Major Business
    • 2.18.3 SMC Laboratories, Inc. Liver Cancer Treatment Drug Product and Solutions
    • 2.18.4 SMC Laboratories, Inc. Liver Cancer Treatment Drug Revenue, Gross Margin and Market Share (2020-2025)
    • 2.18.5 SMC Laboratories, Inc. Recent Developments and Future Plans
  • 2.19 Thermo Fisher Scientific, Inc.
    • 2.19.1 Thermo Fisher Scientific, Inc. Details
    • 2.19.2 Thermo Fisher Scientific, Inc. Major Business
    • 2.19.3 Thermo Fisher Scientific, Inc. Liver Cancer Treatment Drug Product and Solutions
    • 2.19.4 Thermo Fisher Scientific, Inc. Liver Cancer Treatment Drug Revenue, Gross Margin and Market Share (2020-2025)
    • 2.19.5 Thermo Fisher Scientific, Inc. Recent Developments and Future Plans

3 Market Competition, by Players

  • 3.1 Global Liver Cancer Treatment Drug Revenue and Share by Players (2020-2025)
  • 3.2 Market Share Analysis (2024)
    • 3.2.1 Market Share of Liver Cancer Treatment Drug by Company Revenue
    • 3.2.2 Top 3 Liver Cancer Treatment Drug Players Market Share in 2024
    • 3.2.3 Top 6 Liver Cancer Treatment Drug Players Market Share in 2024
  • 3.3 Liver Cancer Treatment Drug Market: Overall Company Footprint Analysis
    • 3.3.1 Liver Cancer Treatment Drug Market: Region Footprint
    • 3.3.2 Liver Cancer Treatment Drug Market: Company Product Type Footprint
    • 3.3.3 Liver Cancer Treatment Drug Market: Company Product Application Footprint
  • 3.4 New Market Entrants and Barriers to Market Entry
  • 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

  • 4.1 Global Liver Cancer Treatment Drug Consumption Value and Market Share by Type (2020-2025)
  • 4.2 Global Liver Cancer Treatment Drug Market Forecast by Type (2026-2031)

5 Market Size Segment by Application

  • 5.1 Global Liver Cancer Treatment Drug Consumption Value Market Share by Application (2020-2025)
  • 5.2 Global Liver Cancer Treatment Drug Market Forecast by Application (2026-2031)

6 North America

  • 6.1 North America Liver Cancer Treatment Drug Consumption Value by Type (2020-2031)
  • 6.2 North America Liver Cancer Treatment Drug Market Size by Application (2020-2031)
  • 6.3 North America Liver Cancer Treatment Drug Market Size by Country
    • 6.3.1 North America Liver Cancer Treatment Drug Consumption Value by Country (2020-2031)
    • 6.3.2 United States Liver Cancer Treatment Drug Market Size and Forecast (2020-2031)
    • 6.3.3 Canada Liver Cancer Treatment Drug Market Size and Forecast (2020-2031)
    • 6.3.4 Mexico Liver Cancer Treatment Drug Market Size and Forecast (2020-2031)

7 Europe

  • 7.1 Europe Liver Cancer Treatment Drug Consumption Value by Type (2020-2031)
  • 7.2 Europe Liver Cancer Treatment Drug Consumption Value by Application (2020-2031)
  • 7.3 Europe Liver Cancer Treatment Drug Market Size by Country
    • 7.3.1 Europe Liver Cancer Treatment Drug Consumption Value by Country (2020-2031)
    • 7.3.2 Germany Liver Cancer Treatment Drug Market Size and Forecast (2020-2031)
    • 7.3.3 France Liver Cancer Treatment Drug Market Size and Forecast (2020-2031)
    • 7.3.4 United Kingdom Liver Cancer Treatment Drug Market Size and Forecast (2020-2031)
    • 7.3.5 Russia Liver Cancer Treatment Drug Market Size and Forecast (2020-2031)
    • 7.3.6 Italy Liver Cancer Treatment Drug Market Size and Forecast (2020-2031)

8 Asia-Pacific

  • 8.1 Asia-Pacific Liver Cancer Treatment Drug Consumption Value by Type (2020-2031)
  • 8.2 Asia-Pacific Liver Cancer Treatment Drug Consumption Value by Application (2020-2031)
  • 8.3 Asia-Pacific Liver Cancer Treatment Drug Market Size by Region
    • 8.3.1 Asia-Pacific Liver Cancer Treatment Drug Consumption Value by Region (2020-2031)
    • 8.3.2 China Liver Cancer Treatment Drug Market Size and Forecast (2020-2031)
    • 8.3.3 Japan Liver Cancer Treatment Drug Market Size and Forecast (2020-2031)
    • 8.3.4 South Korea Liver Cancer Treatment Drug Market Size and Forecast (2020-2031)
    • 8.3.5 India Liver Cancer Treatment Drug Market Size and Forecast (2020-2031)
    • 8.3.6 Southeast Asia Liver Cancer Treatment Drug Market Size and Forecast (2020-2031)
    • 8.3.7 Australia Liver Cancer Treatment Drug Market Size and Forecast (2020-2031)

9 South America

  • 9.1 South America Liver Cancer Treatment Drug Consumption Value by Type (2020-2031)
  • 9.2 South America Liver Cancer Treatment Drug Consumption Value by Application (2020-2031)
  • 9.3 South America Liver Cancer Treatment Drug Market Size by Country
    • 9.3.1 South America Liver Cancer Treatment Drug Consumption Value by Country (2020-2031)
    • 9.3.2 Brazil Liver Cancer Treatment Drug Market Size and Forecast (2020-2031)
    • 9.3.3 Argentina Liver Cancer Treatment Drug Market Size and Forecast (2020-2031)

10 Middle East & Africa

  • 10.1 Middle East & Africa Liver Cancer Treatment Drug Consumption Value by Type (2020-2031)
  • 10.2 Middle East & Africa Liver Cancer Treatment Drug Consumption Value by Application (2020-2031)
  • 10.3 Middle East & Africa Liver Cancer Treatment Drug Market Size by Country
    • 10.3.1 Middle East & Africa Liver Cancer Treatment Drug Consumption Value by Country (2020-2031)
    • 10.3.2 Turkey Liver Cancer Treatment Drug Market Size and Forecast (2020-2031)
    • 10.3.3 Saudi Arabia Liver Cancer Treatment Drug Market Size and Forecast (2020-2031)
    • 10.3.4 UAE Liver Cancer Treatment Drug Market Size and Forecast (2020-2031)

11 Market Dynamics

  • 11.1 Liver Cancer Treatment Drug Market Drivers
  • 11.2 Liver Cancer Treatment Drug Market Restraints
  • 11.3 Liver Cancer Treatment Drug Trends Analysis
  • 11.4 Porters Five Forces Analysis
    • 11.4.1 Threat of New Entrants
    • 11.4.2 Bargaining Power of Suppliers
    • 11.4.3 Bargaining Power of Buyers
    • 11.4.4 Threat of Substitutes
    • 11.4.5 Competitive Rivalry

12 Industry Chain Analysis

  • 12.1 Liver Cancer Treatment Drug Industry Chain
  • 12.2 Liver Cancer Treatment Drug Upstream Analysis
  • 12.3 Liver Cancer Treatment Drug Midstream Analysis
  • 12.4 Liver Cancer Treatment Drug Downstream Analysis

13 Research Findings and Conclusion

    14 Appendix

    • 14.1 Methodology
    • 14.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Liver Cancer Treatment Drug market size was valued at US$ million in 2024 and is forecast to a readjusted size of USD million by 2031 with a CAGR of %during review period.
    The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
    This report is a detailed and comprehensive analysis for global Liver Cancer Treatment Drug market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
    Key Features:
    Global Liver Cancer Treatment Drug market size and forecasts, in consumption value ($ Million), 2020-2031
    Global Liver Cancer Treatment Drug market size and forecasts by region and country, in consumption value ($ Million), 2020-2031
    Global Liver Cancer Treatment Drug market size and forecasts, by Type and by Application, in consumption value ($ Million), 2020-2031
    Global Liver Cancer Treatment Drug market shares of main players, in revenue ($ Million), 2020-2025
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Liver Cancer Treatment Drug
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Liver Cancer Treatment Drug market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include 4SC AG, Alnylam Pharmaceuticals, Inc., AVEO Pharmaceuticals, Inc, Bayer AG, Becton, Dickinson and Co., Bristol-Myers Squibb Co., Celsion Corp., Dicerna Pharmaceuticals, Inc., Eli Lilly and Co., Exelixis, Inc., etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market segmentation
    Liver Cancer Treatment Drug market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    Targeted Therapy
    Radiation Therapy
    Immunotherapy
    Chemotherapy
    Other
    Market segment by Application
    Hepatocellular Carcinoma
    Cholangio Carcinoma
    Hepatoblastoma
    Other
    Market segment by players, this report covers
    4SC AG
    Alnylam Pharmaceuticals, Inc.
    AVEO Pharmaceuticals, Inc
    Bayer AG
    Becton, Dickinson and Co.
    Bristol-Myers Squibb Co.
    Celsion Corp.
    Dicerna Pharmaceuticals, Inc.
    Eli Lilly and Co.
    Exelixis, Inc.
    F. Hoffmann-La Roche, Ltd.
    FibroGen, Inc.
    General Electric Co.(GE Healthcare)
    Merck & Co., Inc.(ArQule, Inc.)
    Novartis International AG
    Nymox Corp.
    Pfizer, Inc.
    SMC Laboratories, Inc.
    Thermo Fisher Scientific, Inc.
    Market segment by regions, regional analysis covers
    North America (United States, Canada and Mexico)
    Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
    Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
    South America (Brazil, Rest of South America)
    Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 13 chapters:
    Chapter 1, to describe Liver Cancer Treatment Drug product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top players of Liver Cancer Treatment Drug, with revenue, gross margin, and global market share of Liver Cancer Treatment Drug from 2020 to 2025.
    Chapter 3, the Liver Cancer Treatment Drug competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
    Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2020 to 2031
    Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2020 to 2025.and Liver Cancer Treatment Drug market forecast, by regions, by Type and by Application, with consumption value, from 2026 to 2031.
    Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
    Chapter 12, the key raw materials and key suppliers, and industry chain of Liver Cancer Treatment Drug.
    Chapter 13, to describe Liver Cancer Treatment Drug research findings and conclusion.

    Buy now